In the current market session, Regeneron Pharmaceuticals Inc. REGN share price is at $695.58, after a 0.06% decrease. Over the past month, the stock spiked by 2.93%, but over the past year, it ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Regeneron is also embroiled in a securities fraud class action lawsuit stemming from a significant stock price drop on October 31, 2024. Shares plunged $84.59 that day, wiping out approximately $9 ...

Key Takeaways - The First Circuit ruled in United States v. Regeneron Pharmaceuticals, Inc., that the government must prove but-for causation ...

It’s now 3–1, with the First Circuit (2025) aligning with the Sixth (2023) and Eighth (2022) Circuits finding the meaning of the words ...

The supplemental biologics license application for Dupixent for the treatment of bullous pemphigoid in adults has been ...

This week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But ...

This was the stock's third consecutive day of gains.

Fossilized olive leaves from a tree that was alive 60,000 years ago on the island of Thira (the modern Santorini) are immortalized in the volcanic ash that encased them after an eruption. The ...